Header image

Session 13A: Structuring success: Legal, IP and deal-making in global biotech

Tracks
Track 1
Friday, October 24, 2025
12:15 PM - 1:00 PM
Visionary Room

Details

Behind every breakthrough lies a web of legal, financial, and strategic frameworks that determine whether innovation can scale globally. This session explores the critical role of intellectual property, deal-making, and cross-border transactions in biotech success. Global Industry experts will unpack how IP strategies underpin valuation, how licensing and partnerships are structured across jurisdictions, and how global capital flows shape company growth. With perspectives spanning legal counsel, executive leadership, and investor relations, the discussion will highlight the interplay between regulation, commercial contracts, and global market entry. Delegates will gain practical insights into how to secure IP, navigate complex deal structures, and build partnerships that ensure Australian biotech innovation can thrive on the global stage.


Speaker

Agenda Item Image
Ms Jane Lowe
Managing Director
IR Department

Chair

Agenda Item Image
Dr. Helen Mutimer
Head of IP Advisory
FB Rice

Panellist

Agenda Item Image
Dr. Chris Nave
Founding Partner & Managing Director
Brandon Capital

Panellist

Agenda Item Image
Ms Naomi Omundson
Partner
McCullough Robertson

Panellist

Derek Small
Co-Founder & CEO
Syndeio Biosciences

Panellist

loading